Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumorsBertrand Routy, Laurence Zitvogel, Christophe Klein et al.|Science|2017Cited by 5.4k
Sustained Type I interferon signaling as a mechanism of resistance to PD-1 blockadeNicolas Jacquelot, Laurence Zitvogel, Takahiro Yamazaki et al.|Cell Research|2019Cited by 246
Predictors of responses to immune checkpoint blockade in advanced melanomaNicolas Jacquelot, Laurence Zitvogel, María P. Roberti et al.|Nature Communications|2017Cited by 201
Blockade of the co-inhibitory molecule PD-1 unleashes ILC2-dependent antitumor immunity in melanomaNicolas Jacquelot, Gabrielle T. Belz|Nature Immunology|2021Cited by 173
Mature Cytotoxic CD56bright/CD16 <i>+</i> Natural Killer Cells Can Infiltrate Lymph Nodes Adjacent to Metastatic MelanomaMeriem Messaoudene, Anne Caignard, Giulia Fregni et al.|Cancer Research|2013Cited by 93